From broker on Novan from Shareholder meeting last week:
Still same Strategy... phase 3 molluscum at year end with a possible partnership in the product as well as another round of funding to start acne and other sciences next year
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.